Cerebral toxoplasmosis in HIV-infected patients over 2015-2018 (a case study of Russia)

O. V. Azovtseva, C. G. Bakulina, A. S. Shelomov, T. N. Trofimova

Research outputpeer-review

Abstract

Cerebral toxoplasmosis is a leading cause of the central nervous system disorders in acquired immune deficiency syndrome (AIDS). This study aimed to investigate the clinical course of cerebral toxoplasmosis in human immunodeficiency virus (HIV)-infected individuals. The study included 90 HIV-infected patients with cerebral toxoplasmosis, who underwent inpatient treatment. In case of positive enzyme immunoassay, HIV infection was confirmed with the immunoblot test. The HIV-1 ribonucleic acid (RNA) level was determined using the polymerase chain reaction (PCR) method. The flow cytometry was used for counting CD4 (cluster of differentiation 4 cells). Pathomorphological examination included the autopsy, gross and microscopic examination of internal organs, histological and other methods. The incidence of cerebral toxoplasmosis significantly increases at the CD4 count below 100 cells/μl, p <0.001, and at the HIV viral load above 50 copies/ml, p <0.05. The clinical picture of cerebral toxoplasmosis included focal symptoms, cognitive impairment, toxic syndrome, mild cerebral symptoms, and a meningeal symptom. Given the absence of a specific clinical picture and the absence of abnormal laboratory and instrumental findings, the cerebral toxoplasmosis needs to be diagnosed with a number diagnostic methods combined: Clinical examination, laboratory testing, immunological examination, molecular genetic testing, and neuroradiological imaging.

Original languageEnglish
JournalEpidemiology and Infection
DOIs
Publication statusAccepted/In press - 2020

Scopus subject areas

  • Epidemiology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Cerebral toxoplasmosis in HIV-infected patients over 2015-2018 (a case study of Russia)'. Together they form a unique fingerprint.

Cite this